Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Return on Invested Capital: 2020-2023

Historic Return on Invested Capital for ADC Therapeutics (ADCT) over the last 2 years, with Sep 2023 value amounting to 3.95%.

  • ADC Therapeutics' Return on Invested Capital was N/A to 3.95% in Q3 2023 from the same period last year, while for Sep 2023 it was 3.95%, marking a year-over-year change of. This contributed to the annual value of -0.00% for FY2022, which is N/A change from last year.
  • According to the latest figures from Q3 2023, ADC Therapeutics' Return on Invested Capital is 3.95%, which was up 418.81% from -1.24% recorded in Q2 2023.
  • In the past 5 years, ADC Therapeutics' Return on Invested Capital ranged from a high of 3.95% in Q3 2023 and a low of -854.17% during Q2 2020.
  • In the last 2 years, ADC Therapeutics' Return on Invested Capital had a median value of -0.03% in 2021 and averaged 0.43%.
  • Data for ADC Therapeutics' Return on Invested Capital shows a peak YoY spiked of 85,414bps (in 2021) over the last 5 years.
  • ADC Therapeutics' Return on Invested Capital (Quarterly) stood at -0.03% in 2020, then remained steady at -0.01% in 2021, then reached 3.95% in 2023.
  • Its Return on Invested Capital stands at 3.95% for Q3 2023, versus -1.24% for Q2 2023 and -0.01% for Q4 2021.